Previous 10 | Next 10 |
home / stock / viv:cc / viv:cc news
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products ...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
Not for Distribution to United States News Wire Services or for Dissemination in the United States. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”) announces that the TSX Venture Exchange has granted an extension of up to 30 day...
Not for Distribution to United States News Wire Services or for Dissemination in the United States. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products ...
Record Year of Progress for OxC-beta TM Adoption Worldwide Supply agreement with AB Vista in United States, Brazil and Thailand compliments existing partnerships in Asia and Mexico Continued positive animal trial results leading to orders, new customer wins...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sci...
The New Offering. Avivagen's management announced yesterday the intention to complete a private placement financing of secured debentures. The gross proceeds of this financing will total up to CAD$6.5 million and will close on March 28, 2022. Bloom Burton Securities is acting as the agent in t...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sci...
News, Short Squeeze, Breakout and More Instantly...
Avivagen Inc. Company Name:
VIV:CC Stock Symbol:
TSXVC Market:
Yangaroo Inc. (YOO:CA) is expected to report for Q1 2024 Blue Horizon Global Capital Corp Com (BHCC:CNX) is expected to report for Q1 2024 GoldMoney Inc. (XAU:CA) is expected to report for Q4 2024 Avivagen Inc. (VIV:CA) is expected to report for Q2 2024 Imperial Ginseng Products L...
Mission Ready Solutions Inc. (MRS.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for Q3 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 ...
Green Impact Partners Inc. (GIP:CA) is expected to report for Q1 2024 AXMIN Inc. (AXM:CA) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 PUDO Inc (PDO:CNX) is expected to report for Q4 2024 Pedro Resources Ltd (VBN:CNX) is expected ...